Actin-binding protein Anillin plays a pivotal role in regulating cytokinesis during the cell cycle, and involves in tumorigenesis and progress. However, the exact regulation mechanism of Anillin in human hepatocellular carcinoma (HCC) remains largely unknown. In this study, we examined and verified the anomalous high expression of Anillin in both HCC patients' specimens and HCC cell lines. High expression of Anillin is associated with dismal clinicopathologic features of HCC patients and poor prognosis. We conducted loss-of and gain-of function studies in HCC Hep3B cells. Anillin presented a significantly facilitating effect on cell proliferation in vitro and induced remarkable tumor growth in vivo. We found that the over-expression of Anillin was driven by a potential axis of miR-138/SOX4. Transcription factor SOX4 presented a high expression profile positive correlated with Anillin, and ChIP assay validated the interaction between SOX4 and the specific sequence of the promoter region of Anillin gene. While, we verified miR-138 as an upstream regulator of SOX4, which is abrogated in HCC cells and exerts degenerating effect on SOX4 mRNA. In our conclusion, Anillin facilitates the cell proliferation and enhances tumor growth of HCC, and is modulated by miR-138/SOX4 axis which regulates the transcriptional activity of Anillin. Findings above demonstrate us a probable axis for HCC diagnosis and treatment. Summary of the main point Anillin facilitates the cell proliferation and enhances tumor growth in HCC. The transcriptional activity of Anillin is modulated by miR-138/SOX4 axis. Findings above demonstrate us a probable axis for HCC diagnosis and treatment.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Introduction: Excessive lengths of partially threaded cannulated screws in medial malleolus fractures are often related to failure of fixation and other complications. This study aimed to analyze the distribution and density of cancellous bone in the medial malleolus among healthy individuals and provide a theoretical basis for determining the lengths of cannulated screws based on preoperative computed tomography (CT) to achieve stable fixation of medial malleolus fractures.Methods: Between January 2012 and December 2016, 100 patients (without ankle fractures) who underwent CT of the distal tibia of the lower extremities were included. Specific levels on the CT images were selected to assess the density and length of valid cancellous bone in the medial malleolus for screw fixation. Meanwhile, we followed up 44 patients who underwent open reduction and internal fixation (ORIF) of medial malleolus fractures based on preoperative CT-based measurements.Results: The valid lengths of cancellous bone in the medial malleolus were significantly different between men and women (p < .05). In addition, there was a significant difference among different age groups (p < .05). The median follow-up duration of patients who underwent ORIF was 14 (range, 12–16) months. All patients were followed up to union without displacement, and no screws were observed to have loosened or backed out. Conclusion: Preoperative CT can help determine the length and location of cannulated screws. Age and gender have a considerable impact on the distribution and density of cancellous bone in the medial malleolus. The density and length of valid cancellous bone decrease with age. The shoulder of the tibial plafond in medial malleolus, which is a weak part of cancellous bone, is a common site of fracture. Short screws are recommended for fixation in elderly patients.Level of Evidence: Level IV
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.